Burnstock G (1972) Purinergic nerves. Pharmacol Rev 24(3):509–581
Article CAS PubMed Google Scholar
Fredholm BB, Jacobson IJAPKA, Klotz KN, Linden J (2001) International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53(4):527–552
Article CAS PubMed Google Scholar
Abbracchio MP, Burnstock G (1994) Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64(3):445–475. https://doi.org/10.1016/0163-7258(94)00048-4
Article CAS PubMed Google Scholar
Burnstock G (2004) Introduction: P2 receptors. Curr Top Med Chem 4(8):793–803
Article CAS PubMed Google Scholar
Franke H, Verkhratsky A, Burnstock G, Illes P (2012) Pathophysiology of astroglial purinergic signalling. Purinergic Signal 8(3):629–657. https://doi.org/10.1007/s11302-012-9300-0
Article CAS PubMed PubMed Central Google Scholar
Jacobson KA et al (2015) Nucleotides acting at P2Y receptors: connecting structure and function. Mol Pharmacol 88(2):220–230. https://doi.org/10.1124/mol.114.095711
Article CAS PubMed PubMed Central Google Scholar
Khakh BS, Bao XR, Labarca C, Lester HA (1999) Neuronal P2X transmitter-gated cation channels change their ion selectivity in seconds. Nat Neurosci 2(4):322–330. https://doi.org/10.1038/7233
Article CAS PubMed Google Scholar
Rafehi M, Muller CE (2018) Tools and drugs for uracil nucleotide-activated P2Y receptors. Pharmacol Ther 190:24–80. https://doi.org/10.1016/j.pharmthera.2018.04.002
Article CAS PubMed Google Scholar
Burnstock G (2006) Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58(1):58–86. https://doi.org/10.1124/pr.58.1.5
Article CAS PubMed Google Scholar
Verkhratsky A, Krishtal OA, Burnstock G (2009) Purinoceptors on neuroglia. Mol Neurobiol 39(3):190–208. https://doi.org/10.1007/s12035-009-8063-2
Article CAS PubMed Google Scholar
Burnstock G, Di Virgilio F (2013) Purinergic signalling and cancer. Purinergic Signal 9(4):491–540. https://doi.org/10.1007/s11302-013-9372-5
Article CAS PubMed PubMed Central Google Scholar
Cekic C, Linden J (2016) Purinergic regulation of the immune system. Nat Rev Immunol 16(3):177–192. https://doi.org/10.1038/nri.2016.4
Article CAS PubMed Google Scholar
Elliott MR et al (2009) Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461(7261):282–286. https://doi.org/10.1038/nature08296
Article CAS PubMed PubMed Central Google Scholar
Lazarowski ER (2012) Vesicular and conductive mechanisms of nucleotide release. Purinergic Signal 8(3):359–373. https://doi.org/10.1007/s11302-012-9304-9
Article CAS PubMed PubMed Central Google Scholar
Volonté C, Apolloni S, Skaper SD, Burnstock G (2012) P2X7 receptors: channels, pores and more. CNS Neurol Disord Drug Targets 11(6):705–721. https://doi.org/10.2174/187152712803581137
Harden TK, Lazarowski ER (1999) Chapter 11 release of ATP and UTP from astrocytoma cells. Prog Brain Res 120:135–143. https://doi.org/10.1016/S0079-6123(08)63551-7
Article CAS PubMed Google Scholar
Di Virgilio F, Adinolfi E (2017) Extracellular purines, purinergic receptors and tumor growth. Oncogene 36(3):293–303. https://doi.org/10.1038/onc.2016.206
Article CAS PubMed Google Scholar
Zimmermann H (2016) Extracellular ATP and other nucleotides—ubiquitous triggers of intercellular messenger release. Purinergic Signal 12(1):25–57. https://doi.org/10.1007/s11302-015-9483-2
Article CAS PubMed Google Scholar
Antonioli L, Pacher P, Vizi ES, Hasko G (2013) CD39 and CD73 in immunity and inflammation. Trends Mol Med 19(6):355–367. https://doi.org/10.1016/j.molmed.2013.03.005
Article CAS PubMed PubMed Central Google Scholar
Kanthi YM, Sutton NR, Pinsky DJ (2014) CD39: interface between vascular thrombosis and inflammation. Curr Atheroscler Rep 16(7):425. https://doi.org/10.1007/s11883-014-0425-1
Article CAS PubMed PubMed Central Google Scholar
Antonioli L, Blandizzi C, Pacher P, Hasko G (2013) Immunity, inflammation and cancer: a leading role for adenosine. Nat Rev Cancer 13(12):842–857. https://doi.org/10.1038/nrc3613
Article CAS PubMed Google Scholar
Stagg J, Smyth MJ (2010) Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 29(39):5346–5358. https://doi.org/10.1038/onc.2010.292
Article CAS PubMed Google Scholar
Pellegatti P, Raffaghello L, Bianchi G, Piccardi F, Pistoia V, Di Virgilio F (2008) Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS One 3(7):e2599. https://doi.org/10.1371/journal.pone.0002599
Article CAS PubMed PubMed Central Google Scholar
Jacob F, Novo CP, Bachert C, Van Crombruggen K (2013) Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses. Purinergic Signal 9(3):285–306. https://doi.org/10.1007/s11302-013-9357-4
Article CAS PubMed PubMed Central Google Scholar
Burnstock G, Evans LC, Bailey MA (2014) Purinergic signalling in the kidney in health and disease. Purinergic Signal 10(1):71–101. https://doi.org/10.1007/s11302-013-9400-5
Article CAS PubMed Google Scholar
Burnstock G (2014) Purinergic signalling in the gastrointestinal tract and related organs in health and disease. Purinergic Signal 10(1):3–50. https://doi.org/10.1007/s11302-013-9397-9
Article CAS PubMed Google Scholar
Pedata F et al (2016) Purinergic signalling in brain ischemia. Neuropharmacology 104:105–130. https://doi.org/10.1016/j.neuropharm.2015.11.007
Article CAS PubMed Google Scholar
Magni G, Riccio D, Ceruti S (2017) Tackling chronic pain and inflammation through the purinergic system. Curr Med Chem. https://doi.org/10.2174/0929867324666170710110630
Lim AW, Talley NJ, Walker MM, Storm G, Hua S (2023) Current status and advances in esophageal drug delivery technology: influence of physiological, pathophysiological and pharmaceutical factors. Drug Deliv 30(1). https://doi.org/10.1080/10717544.2023.2219423
Standring S (2020) Gray’s anatomy international edition: the anatomical basis of clinical practice, 42nd edn. Elsevier Health Sciences
Comments (0)